Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer. [electronic resource]
Producer: 20201204Description: 303-308 p. digitalISSN:- 1365-2710
- Aged
- Biomarkers, Tumor -- blood
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cohort Studies
- Disease Progression
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- administration & dosage
- Retrospective Studies
- Treatment Outcome
- Uric Acid -- blood
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.